Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

Chaperone Leadership

An insightful parallel between bosses and biology

- PMLiVE

‘Moving during a global pandemic was the best professional decision I could have made’

Below we hear from Helena Whelan about her experiences of moving jobs during a Global pandemic and why she chose to return to Nucleus Global.

Nucleus Global

- PMLiVE

Novartis receives FDA breakthrough therapy designation for rare disease med

The Swiss pharma company is eyeing approval in PNH and C3G indications

Patient Partnerships: Challenges and Opportunities for Pharma

Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital, for this live Fireside Chat. Today, we are exploring...

Impetus Digital

Top 10 Tips for Creating Company Culture in a Virtual World

Remote work is here to stay. Learn how companies and employees can thrive in this new environment

Impetus Digital

- PMLiVE

Lilly picks up gene therapy programme in $1bn Prevail Therapeutics acquisition deal

Acquisition includes a number of candidates for neurodegenerative diseases

- PMLiVE

Novo Nordisk launches late-stage study in Alzheimer’s disease

Study will evaluate oral semaglutide in neurodegenerative disease

- PMLiVE

Pfizer/BioNTech COVID-19 vaccine set for roll-out in Germany this month

Germany will begin vaccinating elderly in care homes on 27 December

- PMLiVE

Can digital communications boost behaviour change?

By Lorraine Walters and Federico Marchisio

- PMLiVE

AstraZeneca takes home Company of the Year award at PMEA 2020

The Company of the Year award recognises outstanding customer-centric achievement

- PMLiVE

Valneva launches phase 1/2 COVID-19 vaccine trials in the UK

UK government has pre-ordered 60 million doses of candidate

- PMLiVE

EU fast-tracks review of Pfizer/BioNTech COVID-19 vaccine

CHMP meeting scheduled for 21 December

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links